カテゴリ： Market Monitor Global, 世界, 医療/バイオ

A型肝炎＆B型肝炎予防接種のグローバル市場展望 2023年-2029年：A型肝炎ワクチン、B型肝炎ワクチン

■ 英語タイトル：Hepatitis A and B Vaccination Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5612）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5612
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆医療
■ ページ数：117
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[A型肝炎＆B型肝炎予防接種のグローバル市場展望 2023年-2029年：A型肝炎ワクチン、B型肝炎ワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のA型肝炎＆B型肝炎予防接種市場規模と予測を収録しています。・世界のA型肝炎＆B型肝炎予防接種市場：売上、2018年-2023年、2024年-2029年
・世界のA型肝炎＆B型肝炎予防接種市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のA型肝炎＆B型肝炎予防接種市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「A型肝炎ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

A型肝炎＆B型肝炎予防接種のグローバル主要企業は、GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 LG Life Sciences、 Serum Instituteなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、A型肝炎＆B型肝炎予防接種のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のA型肝炎＆B型肝炎予防接種市場：タイプ別、2018年-2023年、2024年-2029年
世界のA型肝炎＆B型肝炎予防接種市場：タイプ別市場シェア、2022年
・A型肝炎ワクチン、B型肝炎ワクチン

世界のA型肝炎＆B型肝炎予防接種市場：用途別、2018年-2023年、2024年-2029年
世界のA型肝炎＆B型肝炎予防接種市場：用途別市場シェア、2022年
・政府機関、民間、その他

世界のA型肝炎＆B型肝炎予防接種市場：地域・国別、2018年-2023年、2024年-2029年
世界のA型肝炎＆B型肝炎予防接種市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるA型肝炎＆B型肝炎予防接種のグローバル売上、2018年-2023年
・主要企業におけるA型肝炎＆B型肝炎予防接種のグローバル売上シェア、2022年
・主要企業におけるA型肝炎＆B型肝炎予防接種のグローバル販売量、2018年-2023年
・主要企業におけるA型肝炎＆B型肝炎予防接種のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 LG Life Sciences、 Serum Institute

*************************************************************

・調査・分析レポートの概要
A型肝炎＆B型肝炎予防接種市場の定義
市場セグメント
世界のA型肝炎＆B型肝炎予防接種市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のA型肝炎＆B型肝炎予防接種市場規模
世界のA型肝炎＆B型肝炎予防接種市場規模：2022年 VS 2029年
世界のA型肝炎＆B型肝炎予防接種市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのA型肝炎＆B型肝炎予防接種の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のA型肝炎＆B型肝炎予防接種製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：A型肝炎ワクチン、B型肝炎ワクチン
A型肝炎＆B型肝炎予防接種のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：政府機関、民間、その他
A型肝炎＆B型肝炎予防接種の用途別グローバル売上・予測

・地域別市場分析
地域別A型肝炎＆B型肝炎予防接種市場規模 2022年と2029年
地域別A型肝炎＆B型肝炎予防接種売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 LG Life Sciences、 Serum Institute
...

The hepatitis A and hepatitis B vaccines can be given separately or as a combination vaccine. All the shots in the series are needed for long-term protection. The full series of the hepatitis A and hepatitis B vaccines require 2-3 shots, depending on the type of vaccine.
This report aims to provide a comprehensive presentation of the global market for Hepatitis A and B Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A and B Vaccination. This report contains market size and forecasts of Hepatitis A and B Vaccination in global, including the following market information:
Global Hepatitis A and B Vaccination Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hepatitis A and B Vaccination Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Hepatitis A and B Vaccination companies in 2022 (%)
The global Hepatitis A and B Vaccination market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hepatitis A Vaccination Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hepatitis A and B Vaccination include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis A and B Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis A and B Vaccination Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hepatitis A and B Vaccination Market Segment Percentages, by Type, 2022 (%)
Hepatitis A Vaccination
Hepatitis B Vaccination
Global Hepatitis A and B Vaccination Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hepatitis A and B Vaccination Market Segment Percentages, by Application, 2022 (%)
Government Institution
Private Sector
Other
Global Hepatitis A and B Vaccination Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hepatitis A and B Vaccination Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis A and B Vaccination revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatitis A and B Vaccination revenues share in global market, 2022 (%)
Key companies Hepatitis A and B Vaccination sales in global market, 2018-2023 (Estimated), (Units)
Key companies Hepatitis A and B Vaccination sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis A and B Vaccination, market overview.
Chapter 2: Global Hepatitis A and B Vaccination market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatitis A and B Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis A and B Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatitis A and B Vaccination capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Hepatitis A and B Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis A and B Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis A and B Vaccination Overall Market Size
2.1 Global Hepatitis A and B Vaccination Market Size: 2022 VS 2029
2.2 Global Hepatitis A and B Vaccination Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hepatitis A and B Vaccination Sales: 2018-2029
3 Company Landscape
3.1 Top Hepatitis A and B Vaccination Players in Global Market
3.2 Top Global Hepatitis A and B Vaccination Companies Ranked by Revenue
3.3 Global Hepatitis A and B Vaccination Revenue by Companies
3.4 Global Hepatitis A and B Vaccination Sales by Companies
3.5 Global Hepatitis A and B Vaccination Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatitis A and B Vaccination Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatitis A and B Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis A and B Vaccination Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis A and B Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis A and B Vaccination Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hepatitis A and B Vaccination Market Size Markets, 2022 & 2029
4.1.2 Hepatitis A Vaccination
4.1.3 Hepatitis B Vaccination
4.2 By Type – Global Hepatitis A and B Vaccination Revenue & Forecasts
4.2.1 By Type – Global Hepatitis A and B Vaccination Revenue, 2018-2023
4.2.2 By Type – Global Hepatitis A and B Vaccination Revenue, 2024-2029
4.2.3 By Type – Global Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
4.3 By Type – Global Hepatitis A and B Vaccination Sales & Forecasts
4.3.1 By Type – Global Hepatitis A and B Vaccination Sales, 2018-2023
4.3.2 By Type – Global Hepatitis A and B Vaccination Sales, 2024-2029
4.3.3 By Type – Global Hepatitis A and B Vaccination Sales Market Share, 2018-2029
4.4 By Type – Global Hepatitis A and B Vaccination Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hepatitis A and B Vaccination Market Size, 2022 & 2029
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Other
5.2 By Application – Global Hepatitis A and B Vaccination Revenue & Forecasts
5.2.1 By Application – Global Hepatitis A and B Vaccination Revenue, 2018-2023
5.2.2 By Application – Global Hepatitis A and B Vaccination Revenue, 2024-2029
5.2.3 By Application – Global Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
5.3 By Application – Global Hepatitis A and B Vaccination Sales & Forecasts
5.3.1 By Application – Global Hepatitis A and B Vaccination Sales, 2018-2023
5.3.2 By Application – Global Hepatitis A and B Vaccination Sales, 2024-2029
5.3.3 By Application – Global Hepatitis A and B Vaccination Sales Market Share, 2018-2029
5.4 By Application – Global Hepatitis A and B Vaccination Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hepatitis A and B Vaccination Market Size, 2022 & 2029
6.2 By Region – Global Hepatitis A and B Vaccination Revenue & Forecasts
6.2.1 By Region – Global Hepatitis A and B Vaccination Revenue, 2018-2023
6.2.2 By Region – Global Hepatitis A and B Vaccination Revenue, 2024-2029
6.2.3 By Region – Global Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
6.3 By Region – Global Hepatitis A and B Vaccination Sales & Forecasts
6.3.1 By Region – Global Hepatitis A and B Vaccination Sales, 2018-2023
6.3.2 By Region – Global Hepatitis A and B Vaccination Sales, 2024-2029
6.3.3 By Region – Global Hepatitis A and B Vaccination Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hepatitis A and B Vaccination Revenue, 2018-2029
6.4.2 By Country – North America Hepatitis A and B Vaccination Sales, 2018-2029
6.4.3 US Hepatitis A and B Vaccination Market Size, 2018-2029
6.4.4 Canada Hepatitis A and B Vaccination Market Size, 2018-2029
6.4.5 Mexico Hepatitis A and B Vaccination Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hepatitis A and B Vaccination Revenue, 2018-2029
6.5.2 By Country – Europe Hepatitis A and B Vaccination Sales, 2018-2029
6.5.3 Germany Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.4 France Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.5 U.K. Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.6 Italy Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.7 Russia Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.8 Nordic Countries Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.9 Benelux Hepatitis A and B Vaccination Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hepatitis A and B Vaccination Revenue, 2018-2029
6.6.2 By Region – Asia Hepatitis A and B Vaccination Sales, 2018-2029
6.6.3 China Hepatitis A and B Vaccination Market Size, 2018-2029
6.6.4 Japan Hepatitis A and B Vaccination Market Size, 2018-2029
6.6.5 South Korea Hepatitis A and B Vaccination Market Size, 2018-2029
6.6.6 Southeast Asia Hepatitis A and B Vaccination Market Size, 2018-2029
6.6.7 India Hepatitis A and B Vaccination Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hepatitis A and B Vaccination Revenue, 2018-2029
6.7.2 By Country – South America Hepatitis A and B Vaccination Sales, 2018-2029
6.7.3 Brazil Hepatitis A and B Vaccination Market Size, 2018-2029
6.7.4 Argentina Hepatitis A and B Vaccination Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hepatitis A and B Vaccination Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hepatitis A and B Vaccination Sales, 2018-2029
6.8.3 Turkey Hepatitis A and B Vaccination Market Size, 2018-2029
6.8.4 Israel Hepatitis A and B Vaccination Market Size, 2018-2029
6.8.5 Saudi Arabia Hepatitis A and B Vaccination Market Size, 2018-2029
6.8.6 UAE Hepatitis A and B Vaccination Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis A and B Vaccination Major Product Offerings
7.1.4 GSK Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Hepatitis A and B Vaccination Major Product Offerings
7.2.4 Merck Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Hepatitis A and B Vaccination Major Product Offerings
7.3.4 Sanofi Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Sinovac
7.4.1 Sinovac Company Summary
7.4.2 Sinovac Business Overview
7.4.3 Sinovac Hepatitis A and B Vaccination Major Product Offerings
7.4.4 Sinovac Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.4.5 Sinovac Key News & Latest Developments
7.5 Zhejiang Pukang
7.5.1 Zhejiang Pukang Company Summary
7.5.2 Zhejiang Pukang Business Overview
7.5.3 Zhejiang Pukang Hepatitis A and B Vaccination Major Product Offerings
7.5.4 Zhejiang Pukang Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.5.5 Zhejiang Pukang Key News & Latest Developments
7.6 Changchun Institute of Biological
7.6.1 Changchun Institute of Biological Company Summary
7.6.2 Changchun Institute of Biological Business Overview
7.6.3 Changchun Institute of Biological Hepatitis A and B Vaccination Major Product Offerings
7.6.4 Changchun Institute of Biological Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.6.5 Changchun Institute of Biological Key News & Latest Developments
7.7 KM Biologics
7.7.1 KM Biologics Company Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis A and B Vaccination Major Product Offerings
7.7.4 KM Biologics Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.7.5 KM Biologics Key News & Latest Developments
7.8 IMBCAMS
7.8.1 IMBCAMS Company Summary
7.8.2 IMBCAMS Business Overview
7.8.3 IMBCAMS Hepatitis A and B Vaccination Major Product Offerings
7.8.4 IMBCAMS Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.8.5 IMBCAMS Key News & Latest Developments
7.9 Convac
7.9.1 Convac Company Summary
7.9.2 Convac Business Overview
7.9.3 Convac Hepatitis A and B Vaccination Major Product Offerings
7.9.4 Convac Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.9.5 Convac Key News & Latest Developments
7.10 NCPC
7.10.1 NCPC Company Summary
7.10.2 NCPC Business Overview
7.10.3 NCPC Hepatitis A and B Vaccination Major Product Offerings
7.10.4 NCPC Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.10.5 NCPC Key News & Latest Developments
7.11 Bio Kangtai
7.11.1 Bio Kangtai Company Summary
7.11.2 Bio Kangtai Hepatitis A and B Vaccination Business Overview
7.11.3 Bio Kangtai Hepatitis A and B Vaccination Major Product Offerings
7.11.4 Bio Kangtai Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.11.5 Bio Kangtai Key News & Latest Developments
7.12 Dynavax
7.12.1 Dynavax Company Summary
7.12.2 Dynavax Hepatitis A and B Vaccination Business Overview
7.12.3 Dynavax Hepatitis A and B Vaccination Major Product Offerings
7.12.4 Dynavax Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.12.5 Dynavax Key News & Latest Developments
7.13 Hissen
7.13.1 Hissen Company Summary
7.13.2 Hissen Hepatitis A and B Vaccination Business Overview
7.13.3 Hissen Hepatitis A and B Vaccination Major Product Offerings
7.13.4 Hissen Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.13.5 Hissen Key News & Latest Developments
7.14 LG Life Sciences
7.14.1 LG Life Sciences Company Summary
7.14.2 LG Life Sciences Business Overview
7.14.3 LG Life Sciences Hepatitis A and B Vaccination Major Product Offerings
7.14.4 LG Life Sciences Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.14.5 LG Life Sciences Key News & Latest Developments
7.15 Serum Institute
7.15.1 Serum Institute Company Summary
7.15.2 Serum Institute Business Overview
7.15.3 Serum Institute Hepatitis A and B Vaccination Major Product Offerings
7.15.4 Serum Institute Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.15.5 Serum Institute Key News & Latest Developments
8 Global Hepatitis A and B Vaccination Production Capacity, Analysis
8.1 Global Hepatitis A and B Vaccination Production Capacity, 2018-2029
8.2 Hepatitis A and B Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis A and B Vaccination Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis A and B Vaccination Supply Chain Analysis
10.1 Hepatitis A and B Vaccination Industry Value Chain
10.2 Hepatitis A and B Vaccination Upstream Market
10.3 Hepatitis A and B Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis A and B Vaccination Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のトラベルワクチン市場予測2024年-2032年：構成別（単ワクチン、混合ワクチン）、疾患別（A型肝炎、DPT、黄熱病、腸チフス、B型肝炎、はしか・おたふくかぜ、狂犬病、髄膜炎菌、水痘、日本脳炎、その他）、地域別
  • インフルエンザ予防接種のグローバル市場展望 2023年-2029年：3価インフルエンザワクチン、4価インフルエンザワクチン
  • 百日咳ワクチン接種のグローバル市場展望 2023年-2029年：無細胞ワクチン、全細胞ワクチン
  • 動物用ワクチンのグローバル市場展望 2023年-2029年：弱毒生ワクチン、不活化ワクチン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5612 )"A型肝炎＆B型肝炎予防接種のグローバル市場展望 2023年-2029年：A型肝炎ワクチン、B型肝炎ワクチン" (英文：Hepatitis A and B Vaccination Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。